versión impresa ISSN 1131-5768
Recently, acyclovir use has been proposed for the treatment of idiopatic acute paralysis due to the hypothetical viral origin of the disease. Several trials has tried to conclude that acyclovir-prednisona is superior to prednisone alone. We review the latest studies to define protocols in Primary Health Care for the medical treatment of idiopatic facial paralisis but current evidence does not support the recomendation that acyclovir should be use in this disorder.
Palabras clave : Idiopatic acute paralysis; Acyclovir; Prednisone; Treatment.